Across TCGA pan-cancer cohorts, PAGE1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PAGE1 data layer compared with 18 for mass-spec protein.
The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher PAGE1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PAGE1 expression acts as an unfavorable survival marker.
PAAD and UCEC are the cancer types where PAGE1 Mutation most reproducibly stratifies survival.